Sushilla Van Schoonhoven
Vienna, 1090, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Fibroblast growth factor receptor 4 promotes glioblastoma progression: a central role of integrin-mediated cell invasiveness.
Journal: Acta neuropathologica communications
Published: February 16, 2022
Landomycins as glutathione-depleting agents and natural fluorescent probes for cellular Michael adduct-dependent quinone metabolism.
Journal: Communications chemistry
Published: August 04, 2021
Non-viral gene delivery of the oncotoxic protein NS1 for treatment of hepatocellular carcinoma.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 28, 2020
TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAFV600E/TERT promoter double-mutated glioma.
Journal: Acta neuropathologica communications
Published: June 24, 2019
Synthesis and biological evaluation of biotin-conjugated anticancer thiosemicarbazones and their iron(III) and copper(II) complexes.
Journal: Journal of inorganic biochemistry
Published: June 14, 2018
Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 21, 2017
CD44 drives aggressiveness and chemoresistance of a metastatic human osteosarcoma xenograft model.
Journal: Oncotarget
Published: May 05, 2017
Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibition.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 01, 2017
Self-assembled Pt2L2 boxes strongly bind G-quadruplex DNA and influence gene expression in cancer cells.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: December 06, 2016
Loss of CUL4A expression is underlying cisplatin hypersensitivity in colorectal carcinoma cells with acquired trabectedin resistance.
Journal: British journal of cancer
Published: December 05, 2016
Last Updated: 09/26/2026